Willis Towers Watson Operating Cash Flow decreased by 101.3% to -$10.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 71.4%, from -$35.00M to -$10.00M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows a downward trend with a -3.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $494.00M | $1.51B | $184.00M | $21.00M | $237.00M | $179.00M | $375.00M | $134.00M | $296.00M | $393.00M | $522.00M | $24.00M | $407.00M | $482.00M | $599.00M | -$35.00M | $361.00M | $678.00M | $771.00M | -$10.00M |
| QoQ Change | — | +205.9% | -87.8% | -88.6% | >999% | -24.5% | +109.5% | -64.3% | +120.9% | +32.8% | +32.8% | -95.4% | >999% | +18.4% | +24.3% | -105.8% | >999% | +87.8% | +13.7% | -101.3% |
| YoY Change | — | — | — | — | -52.0% | -88.2% | +103.8% | +538.1% | +24.9% | +119.6% | +39.2% | -82.1% | +37.5% | +22.6% | +14.8% | -245.8% | -11.3% | +40.7% | +28.7% | +71.4% |